Edition:
United Kingdom

Biomerica Inc (BMRA.OQ)

BMRA.OQ on NASDAQ Stock Exchange Capital Market

3.41USD
5:59pm GMT
Change (% chg)

$-0.13 (-3.67%)
Prev Close
$3.54
Open
$3.55
Day's High
$3.55
Day's Low
$3.41
Volume
158
Avg. Vol
1,905
52-wk High
$3.79
52-wk Low
$1.92

Latest Key Developments (Source: Significant Developments)

Biomerica extends license agreement with Celtis Pharm
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Biomerica Inc ::Biomerica extends exclusive license agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019.Biomerica Inc - has extended its exclusive license agreement with Celtis Pharm Co. Ltd of South Korea​.Biomerica - ‍term of exclusivity agreement is five years with an additional two years for telcon to receive Korean FDA clearance​.Biomerica - agreement may be cancelled if co has not obtained final clearance for sale of products in U.S. from FDA on or before December 31, 2019​.  Full Article

Biomerica Inc Q1 ‍net sales $1.4 million
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Biomerica Inc :Net sales of $1.4 million for three months ending August 31, 2017, an increase of 2.4%​.Net loss for three months ended August 31, 2017 was $207,059 compared to a net loss of $55,417 during same period in fiscal 2017​.  Full Article

BRIEF-Biomerica extends license agreement with Celtis Pharm

* Biomerica extends exclusive license agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019